Epileptic seizures induced by dexmedetomidine in a neonate

Brain and Development

Volumn 35, Issue 4, 2013, Pages 360-362

  Kubota, Tetsuo ^a   Fukasawa, Tatsuya ^a   Kitamura, Erina ^a   Magota, Miyuki ^a   Kato, Yuichi ^a   Natsume, Jun ^b   Okumura, Akihisa ^c  

^a ANJO KOSEI HOSPITAL   (Japan)

^b NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Abnormal movements; Amplitude integrated EEG; Dexmedetomidine; Neonatal seizure

Indexed keywords

DEXMEDETOMIDINE; LUNG SURFACTANT; MIDAZOLAM;

ANTICONVULSANT THERAPY; ARTICLE; ARTIFICIAL VENTILATION; BRAZIL; CASE REPORT; DELTA RHYTHM; DRUG DOSE INCREASE; DRUG WITHDRAWAL; ELECTRODE; ELECTROENCEPHALOGRAM; HUMAN; HYPERTENSION; HYPOTENSION; HYPOTHERMIA; INFANT; LOCUS CERULEUS; MALE; NEONATAL RESPIRATORY DISTRESS SYNDROME; NEWBORN DISEASE; NEWBORN INTENSIVE CARE; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; OXYGEN DESATURATION; SEIZURE; SINGLE DRUG DOSE; THETA RHYTHM; TRANSIENT TACHYPNEA OF THE NEWBORN;

ANALGESICS, NON-NARCOTIC; DEXMEDETOMIDINE; ELECTROENCEPHALOGRAPHY; EPILEPSY; HUMANS; INFANT, NEWBORN; MALE; RESPIRATION, ARTIFICIAL;

EID: 84875518679     PISSN: 03877604     EISSN: 18727131     Source Type: Journal    
DOI: 10.1016/j.braindev.2012.05.011     Document Type: Article

References (12)

1. Thewissen L., Allegaert K. Analgosedation in neonates: do we still need additional tools after 30 years of clinical research?. Arch Dis Child Educ Pract Ed 2011, 96:112-118.
2. Potts A.L., Warman G.R., Anderson B.J. Dexmedetomidine disposition in children: a population analysis. Paediatr Anaesth 2008, 18:722-730.
3. Guerrini R., Belmonte A., Genton P. Antiepileptic drug-induced worsening of seizures in children. Epilepsia 1998, 39(Suppl. 3):S2-S10.
4. van den Anker J.N., Sauer P.J. The use of midazolam in the preterm neonate. Eur J Pediatr 1992, 151:152.
5. Bergman I., Steeves M., Burckart G., Thompson A. Reversible neurologic abnormalities associated with prolonged intravenous midazolam and fentanyl administration. J Pediatr 1991, 119:644-649.
6. Su F., Hammer G.B. Dexmedetomidine: pediatric pharmacology, clinical uses and safety. Expert Opin Drug Saf 2011, 10:55-66.
7. Krahl S.E., Clark K.B., Smith D.C., Browning R.A. Locus coeruleus lesions suppress the seizure-attenuating effects of vagus nerve stimulation. Epilepsia 1998, 39:709-714.
8. Miyazaki Y., Adachi T., Kurata J., Utsumi J., Shichino T., Segawa H. Dexmedetomidine reduces seizure threshold during enflurane anaesthesia in cats. Br J Anaesth 1999, 82:935-937.
9. Whittington R.A., Virag L. Dexmedetomidine-induced decreases in accumbal dopamine in the rat are partly mediated via the locus coeruleus. Anesth Analg 2006, 102:448-455.
10. Tobias J.D., Gupta P., Naguib A., Yates A.R. Dexmedetomidine: applications for the pediatric patient with congenital heart disease. Pediatr Cardiol 2011, 32:1075-1087.
11. Mason K.P., O'Mahony E., Zurakowski D., Libenson M.H. Effects of dexmedetomidine sedation on the EEG in children. Paediatr Anaesth 2009, 19:1175-1183.
12. Potts A.L., Anderson B.J., Warman G.R., Lerman J., Diaz S.M., Vilo S. Dexmedetomidine pharmacokinetics in pediatric intensive care - a pooled analysis. Paediatr Anaesth 2009, 19:1119-1129.